Online survey of long-term effects of treatments for breast cancer in men

Male breast cancer accounts for approximately 1% of all breast cancer diagnoses. There is a lack of information on late effects of breast cancer treatment in men. An online survey directed towards male breast cancer patients (n=127; median age 64 years) found that 72% of patients experienced late effects secondary to their cancer or cancer treatment. Most patients reported fatigue and fear of recurrence. Axillary lymph node dissection was associated with lymphedema and difficulty with arm and shoulder movement. Systemic chemotherapy was related to bothersome hair loss and changes in interest in sex. Endocrine therapy was associated with feeling less masculine. The authors conclude that these late effects should be discussed with the patients.